DALLAS COUNTY, IOWA – Today, Sen. Chuck Grassley (R-Iowa), former chair and current member of the Finance Committee, held a Q&A with Sumpter Pharmacy employees and community members to Adel. They discussed the bipartisan bills Grassley is pushing to lower insulin costs, hold Pharmacy Benefit Managers (PBMs) accountable and establish more competition to lower prescription drug prices. Grassley is again calling on Majority Leader Chuck Schumer (DN.Y.) to hold votes on five bipartisan bills he is leading to lower drug costs.
“Through bipartisan bills, hearings and investigations, I have been successful in helping Iowans pay for their medications – including creating Medicare Part D, releasing an in-depth report exposing Medicare pricing systems insulin and passing laws like the Right of Reimbursement Act and CREATE law to reduce costs. But there is still work to be done, and that is why I have continued to push for a full Senate vote on five of my bills that have already passed through committee with bipartisan support. I appreciated having the opportunity to discuss these proposals with Adel today. I will continue to work closely with local pharmacies to ensure that Iowans in all areas of the state can get the medications they need at an affordable price,” said Grassley.
“We appreciate the chance to share with Senator Grassley the serious challenges that threaten the viability of local independent pharmacies throughout Iowa and the United States,” said Leslie Herron, pharmacist and owner of Sumpter Pharmacy.
Grassley meets Iowans at Sumpter’s Pharmacy in Adel. Additional photos are available here.
Grassley also raised concerns about reduced pharmacy access under TRICARE’s PBM contract with Express Scripts. On September 29, he joined his Senate colleagues to seek answers on the ability of TRICARE recipients to maintain access to local pharmacies. The Department of Defense (DoD) did not provide satisfactory answers. Grassley followed up with another letter to the DoD asking about TRICARE’s PBM and the agency’s oversight of the PBM contract. This letter can be found here.
In addition to these proposals, Grassley is the author of the Prescription Drug Price Reduction Act (PDPRA), which includes 25 bipartisan provisions to establish accountability and transparency in the pharmaceutical industry. He also supports Sens’s bipartisan bill. Susan Collins (R-Maine) and Jeanne Shaheen (DN.H.) who set a $35 cap on insulin.
Learn more about Grassley’s bipartisan work to lower prescription drug prices HERE.